These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 36165017)

  • 21. Intramolecular recombination enables the formation of hepatitis B virus (HBV) cccDNA in mice after HBV genome transfer using recombinant AAV vectors.
    Ko C; Su J; Festag J; Bester R; Kosinska AD; Protzer U
    Antiviral Res; 2021 Oct; 194():105140. PubMed ID: 34284057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HBx Regulation on HBV Pregenome Promoter in the Episomal Form Versus the Integrated Form.
    Ding H; Hu S; Zhu H; Liu Z; Li Y; Liu J; Li X; Han S; Sun S
    Discov Med; 2023 Apr; 35(175):124-130. PubMed ID: 37105923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferon-inducible MX2 is a host restriction factor of hepatitis B virus replication.
    Wang YX; Niklasch M; Liu T; Wang Y; Shi B; Yuan W; Baumert TF; Yuan Z; Tong S; Nassal M; Wen YM
    J Hepatol; 2020 May; 72(5):865-876. PubMed ID: 31863794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis B virus X protein stimulates gene expression selectively from extrachromosomal DNA templates.
    van Breugel PC; Robert EI; Mueller H; Decorsière A; Zoulim F; Hantz O; Strubin M
    Hepatology; 2012 Dec; 56(6):2116-24. PubMed ID: 22744635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting Hepatitis B Virus Covalently Closed Circular DNA and Hepatitis B Virus X Protein: Recent Advances and New Approaches.
    Prescott NA; Bram Y; Schwartz RE; David Y
    ACS Infect Dis; 2019 Oct; 5(10):1657-1667. PubMed ID: 31525994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of the hepatitis B virus recombinant baculovirus-HepG2 system to study the effects of (-)-beta-2',3'-dideoxy-3'-thiacytidine on replication of hepatitis B virus and accumulation of covalently closed circular DNA.
    Delaney WE; Miller TG; Isom HC
    Antimicrob Agents Chemother; 1999 Aug; 43(8):2017-26. PubMed ID: 10428929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peroxiredoxin 1, a Novel HBx-Interacting Protein, Interacts with Exosome Component 5 and Negatively Regulates Hepatitis B Virus (HBV) Propagation through Degradation of HBV RNA.
    Deng L; Gan X; Ito M; Chen M; Aly HH; Matsui C; Abe T; Watashi K; Wakita T; Suzuki T; Okamoto T; Matsuura Y; Mizokami M; Shoji I; Hotta H
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30567989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HBV T1719G mutation reduced HBV replication through mutant Enh II and HBx protein in vitro.
    Jiao F; Shen C; Ning J; Zhang T; Chen X; Lu F
    J Viral Hepat; 2019 Jun; 26(6):710-717. PubMed ID: 30706588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Novel Mouse Model Harboring Hepatitis B Virus Covalently Closed Circular DNA.
    Xu Z; Zhao L; Zhong Y; Zhu C; Zhao K; Teng Y; Cheng X; Chen Q; Xia Y
    Cell Mol Gastroenterol Hepatol; 2022; 13(4):1001-1017. PubMed ID: 34896285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Host transcription factor Speckled 110 kDa (Sp110), a nuclear body protein, is hijacked by hepatitis B virus protein X for viral persistence.
    Sengupta I; Das D; Singh SP; Chakravarty R; Das C
    J Biol Chem; 2017 Dec; 292(50):20379-20393. PubMed ID: 29046350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of disubstituted sulfonamide compounds as specific inhibitors of hepatitis B virus covalently closed circular DNA formation.
    Cai D; Mills C; Yu W; Yan R; Aldrich CE; Saputelli JR; Mason WS; Xu X; Guo JT; Block TM; Cuconati A; Guo H
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4277-88. PubMed ID: 22644022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PRMT5 restricts hepatitis B virus replication through epigenetic repression of covalently closed circular DNA transcription and interference with pregenomic RNA encapsidation.
    Zhang W; Chen J; Wu M; Zhang X; Zhang M; Yue L; Li Y; Liu J; Li B; Shen F; Wang Y; Bai L; Protzer U; Levrero M; Yuan Z
    Hepatology; 2017 Aug; 66(2):398-415. PubMed ID: 28236308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HBVcircle: A novel tool to investigate hepatitis B virus covalently closed circular DNA.
    Yan Z; Zeng J; Yu Y; Xiang K; Hu H; Zhou X; Gu L; Wang L; Zhao J; Young JAT; Gao L
    J Hepatol; 2017 Jun; 66(6):1149-1157. PubMed ID: 28213165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Establishment of Cre-mediated HBV recombinant cccDNA (rcccDNA) cell line for cccDNA biology and antiviral screening assays.
    Wu M; Li J; Yue L; Bai L; Li Y; Chen J; Zhang X; Yuan Z
    Antiviral Res; 2018 Apr; 152():45-52. PubMed ID: 29432776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Flap endonuclease 1 is involved in cccDNA formation in the hepatitis B virus.
    Kitamura K; Que L; Shimadu M; Koura M; Ishihara Y; Wakae K; Nakamura T; Watashi K; Wakita T; Muramatsu M
    PLoS Pathog; 2018 Jun; 14(6):e1007124. PubMed ID: 29928064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of the host DNA-repair enzyme TDP2 in formation of the covalently closed circular DNA persistence reservoir of hepatitis B viruses.
    Königer C; Wingert I; Marsmann M; Rösler C; Beck J; Nassal M
    Proc Natl Acad Sci U S A; 2014 Oct; 111(40):E4244-53. PubMed ID: 25201958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chromosome remodeling related to hepatitis B virus replication in HepG2 cells.
    Gong Q; Chen S; Guo J; Sun H; Zheng G; Liu Q; Ren H; He S
    DNA Cell Biol; 2011 Jun; 30(6):347-54. PubMed ID: 21345131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HBx represses WDR77 to enhance HBV replication by DDB1-mediated WDR77 degradation in the liver.
    Yuan H; Zhao L; Yuan Y; Yun H; Zheng W; Geng Y; Yang G; Wang Y; Zhao M; Zhang X
    Theranostics; 2021; 11(17):8362-8378. PubMed ID: 34373747
    [No Abstract]   [Full Text] [Related]  

  • 39. Anti-HBV drugs suppress the growth of HBV-related hepatoma cells via down-regulation of hepatitis B virus X protein.
    Zhang S; Gao S; Zhao M; Liu Y; Bu Y; Jiang Q; Zhao Q; Ye L; Zhang X
    Cancer Lett; 2017 Apr; 392():94-104. PubMed ID: 28192212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of postoperative hepatitis B virus reactivation in hepatocellular carcinoma patients who formerly had naturally suppressed virus.
    Lee JI; Kim JK; Chang HY; Lee JW; Kim JM; Chung HJ; Kim YS; Lee KS
    J Gastroenterol Hepatol; 2014 May; 29(5):1019-27. PubMed ID: 24325315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.